Market Size of Cryosurgery Devices Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
CAGR | 6.50 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Cryosurgery Devices Market Analysis
The Cryosurgery Devices Market is expected to grow at a CAGR of over 6.5% during the forecast period.
COVID-19 had a significant impact on the growth of the market over the pandemic period. The demand for cryosurgery and cryotherapy was notably impacted to overcome the post-COVID symptoms among the infected patients. For instance, the article published by CPS published in January 2022, cryotherapy is an innovative treatment for post-COVID symptoms like loss of taste/smell, fatigue, and pain. The whole body cryotherapy among COVID-19-infected patients is used to reduce inflammation, improve blood flow, relieve pain, increase energy, and more. Thus, the benefits of cryotherapy and surgery devices during COVID-19 had a significant impact on the growth of the market during the pandemic period. In addition, the demand for cryosurgery devices is expected to remain impacted due to the increasing focus on treating various chronic diseases during the post-pandemic period over the forecast period.
The cryosurgery devices market is expected to register a boost in its growth rate due to increasing disorders, such as cardiovascular diseases and skin disorders. For instance, the British Heart Foundation (BHF) data published in January 2022 reported that in 2021, the most common heart conditions affected globally were coronary (ischemic) heart disease (global prevalence estimated at 200 million), peripheral arterial (vascular) disease (110 million), stroke (100 million) and atrial fibrillation (60 million). The report also mentioned that the prevalence of heart and circulatory diseases in North America was 46 million, in Europe 99 million, in Africa 58 million, in South America 32 million, and in Asia and Australia 310 million in 2021. For instance, as per the WHO data published in February 2022, in 2021, there were an estimated 1.9 million new cancer cases diagnosed in the United States. The report also mentioned that each year, approximately 400,000 children develop cancer globally. Cervical cancer is the most common in 23 countries, such as Eswatini, India, South Africa, Latin America, and others. The most common cancers are breast, lung, colon and rectum, and prostate cancers. Thus, the increasing prevalence of chronic disorders is expected to drive the demand for cryosurgery devices, thereby contributing to the growth of the market.
On the other hand, the increasing product launches by various key market players are also expected to drive the market's growth over the forecast period. For instance, in January 2021, Pregna International launched a CO-2-based cryotherapy device to help fight cervical cancer. This device was developed by Jhpiego for the treatment of cervical pre-cancerous lesions.
However, the stringent regulatory guidelines and reimbursement issues are expected to restrain the market's growth over the forecast period.
Cryosurgery Devices Industry Segmentation
As per the scope of the report, cryosurgery devices are surgical instruments used to freeze and destroy abnormal cells. These minimally invasive tools may be applied to treat a variety of conditions ranging from skin lesions to internal malignancies.
The Cryosurgery Devices Market is segmented by Product Type (Tissue Contact Probes, Tissue Spray Probes, and Epidermal and Subcutaneous Cryoablation Devices), Application (Surgeries (Oncology, Cardiology, Dermatology, and Other Applications), Pain Management, and Recovery, Health and Beauty), and End-user (Hospital and Cryotherapy Center)and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (USD million) for the above segments.
By Product Type | |
Tissue Contact Probes | |
Tissue Spray Probes | |
Epidermal and Subcutaneous Cryoablation Devices |
By Application | ||||||
| ||||||
Pain Management | ||||||
Recovery, Health, and Beauty |
By End User | |
Hospital | |
Cryotherapy Center |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Cryosurgery Devices Market Size Summary
The Cryosurgery Devices Market is poised for significant growth, driven by the increasing prevalence of chronic diseases such as cardiovascular and skin disorders. The market's expansion is further bolstered by the rising demand for minimally invasive surgical procedures and the effectiveness of cryosurgery devices in pain management. The COVID-19 pandemic has also played a role in shaping market dynamics, as cryotherapy emerged as a treatment for post-COVID symptoms, thereby enhancing the market's visibility and application. The introduction of innovative products by key market players, such as CO-2-based cryotherapy devices and cryo nerve block therapy, is expected to propel market growth. However, challenges such as stringent regulatory guidelines and reimbursement issues may pose constraints to the market's expansion.
North America is anticipated to hold a substantial share of the Cryosurgery Devices Market, attributed to the high burden of chronic disorders and the presence of major market players engaging in frequent product launches. The region's advanced healthcare infrastructure and the growing demand for minimally invasive surgeries further contribute to market growth. The market is moderately fragmented, with prominent companies like Harvard Bioscience Inc., AtriCure Inc., and Brymill Cryogenic Systems leading the competitive landscape. The ongoing development and approval of innovative products, such as the C2 CryoBallon ablation system, are expected to enhance the market's growth trajectory in the coming years.
Cryosurgery Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Burden of Chronic Diseases
-
1.2.2 Rising Preference for Minimally Invasive Surgeries
-
-
1.3 Market Restraints
-
1.3.1 Stringent Regulatory Guidelines and Reimbursement Issues
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Value - in USD Million)
-
2.1 By Product Type
-
2.1.1 Tissue Contact Probes
-
2.1.2 Tissue Spray Probes
-
2.1.3 Epidermal and Subcutaneous Cryoablation Devices
-
-
2.2 By Application
-
2.2.1 Surgeries
-
2.2.1.1 Oncology
-
2.2.1.2 Cardiology
-
2.2.1.3 Dermatology
-
2.2.1.4 Other Applications
-
-
2.2.2 Pain Management
-
2.2.3 Recovery, Health, and Beauty
-
-
2.3 By End User
-
2.3.1 Hospital
-
2.3.2 Cryotherapy Center
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Cryosurgery Devices Market Size FAQs
What is the current Cryosurgery Devices Market size?
The Cryosurgery Devices Market is projected to register a CAGR of 6.5% during the forecast period (2024-2029)
Who are the key players in Cryosurgery Devices Market?
Cardinal Health, Cryoconcepts, Cooper Surgical, AtriCure Inc. and Cortex Technology are the major companies operating in the Cryosurgery Devices Market.